Series A · AI & Machine Learning · Stockholm, Sweden · Founded 2019 · 10–50 employees
Stratipath is a Karolinska Institutet spin-out developing AI-based precision diagnostics for cancer treatment decisions. Their flagship product, Stratipath Breast, uses deep learning to analyze routine histopathology images and provide risk profiling for breast cancer patients, offering a faster and more cost-effective alternative to expensive molecular assays. The company has achieved CE-IVD regulatory approval and is already deployed in clinical settings across Europe. They've secured Series A funding and won prestigious awards including the Athena Prize for healthcare innovation.
No open roles listed right now.